HLA-E and neoplasm: Enzyme-induced size-reduction can enhance the drug accumulation and penetration in tumor tissue, and meanwhile, the unique ROS-driven deselenization led to the downregulation of HLA-E expression in tumor cells, which could be further facilitated by DOX, suggesting the potential of on-demand activation of NK cell-mediated immunotherapy.